Work

Preliminary Results From a Phase Ib Study of Isatuximab in Combination with Pomalidomide (Pom) and Dexamethasone (Dex) in Relapsed and Refractory Multiple Myeloma (RRMM)

Year: 2017

Type: article

Study design: Clinical Trial

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2017.03.028

Authors: Paul Richardson, Joseph Mikhael, Saad Usmani, Napoor Raje, William Bensinger, Frank Campana, Lei Gao, Franck Dubin, Claudine Wack, Kenneth C. Anderson

Institutions: Harvard University, Dana-Farber Cancer Institute, Mayo Clinic in Arizona, Carolinas Healthcare System, Levine Cancer Institute, Massachusetts General Hospital, Swedish Medical Center, Sanofi (France)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2606140494

FWCI: 3.616

Cites:

Cited by: 21

Related to: 10